Throughout SARS-CoV-2 entrance, ACE2 becomes downregulated, which consequently results in a high ACE/ACE2 ratio contributing to the progression of pre-exciting pro-inflammatory responses and subsequently worsen outcomes from COVID-19 (34). The gene discussed is ACE2; the disease is COVID-19.